UB Paderborn / Katalog / Suche / in CDI

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Blood, 2009-10, Vol.114 (16), p.3382-3391

2009

Volltextzugriff (PDF)

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

Blood, 2020-04, Vol.135 (14), p.1124-1132

2020

Volltextzugriff (PDF)

Combination of 5-Azacytidine and ABT-199 Has a Synergistic Apoptotic Effect in High-Risk MDS/sAML after HMA Failure

Blood, 2016-12, Vol.128 (22), p.4297-4297

2016

Volltextzugriff (PDF)

An Evaluation of the Impact of Recurrent Venous Thromboembolic Disease and Hemorrhagic Events within the Managed Care Setting

Blood, 2004-11, Vol.104 (11), p.2207-2207

2004

Volltextzugriff (PDF)

International Normalized Ratio (INR) Monitoring in Patients with Recurrent Venous Thromboembolism (VTE): Opportunity for Improvement in Quality of Management?

Blood, 2004-11, Vol.104 (11), p.2202-2202

2004

Volltextzugriff (PDF)

Anti-Leukemia Potential of Interleukin-2 Activated Natural Killer Cells After Bone Marrow Transplantation for Chronic Myelogenous Leukemia

Blood, 1990-06, Vol.75 (11), p.2250-2262

1990

Volltextzugriff (PDF)

Immune Thrombocytopenia in Lymphoproliferative Diseases

Blood, 1979-04, Vol.53 (4), p.545-551

1979

Volltextzugriff (PDF)

Interleukin 2-Activated Killer Cells in Patients Following Transplants of Soybean Lectin-Separated and E Rosette-Depleted Bone Marrow

Blood, 1987-12, Vol.70 (6), p.1893-1903

1987

Volltextzugriff (PDF)

Platelet-bound Complement (C3) in Immune Thrombocytopenia

Blood, 1977-12, Vol.50 (6), p.1129-1136

1977

Volltextzugriff (PDF)

Platelet-bound complement (C3) in immune thrombocytopenia

Blood, 1977-12, Vol.50 (6), p.1129-1136

1977

Volltextzugriff (PDF)

Immune thrombocytopenia in lymphoproliferative diseases

Blood, 1979-04, Vol.53 (4), p.545-551

1979

Volltextzugriff (PDF)

Treatment of Chronic Granulocytic Leukemia With Melphalan

Blood, 1978-04, Vol.51 (4), p.571-577

1978

Volltextzugriff (PDF)

Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia

Blood, 1990-06, Vol.75 (11), p.2250-2262

1990

Volltextzugriff (PDF)

Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow

Blood, 1987-12, Vol.70 (6), p.1893-1903

1987

Volltextzugriff (PDF)

Treatment of chronic granulocytic leukemia with melphalan

Blood, 1978-04, Vol.51 (4), p.571-577

1978

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

Combination of 5-Azacytidine and ABT-199 Has a Synergistic Apoptotic Effect in High-Risk MDS/sAML after HMA Failure

An Evaluation of the Impact of Recurrent Venous Thromboembolic Disease and Hemorrhagic Events within the Managed Care Setting

International Normalized Ratio (INR) Monitoring in Patients with Recurrent Venous Thromboembolism (VTE): Opportunity for Improvement in Quality of Management?

Anti-Leukemia Potential of Interleukin-2 Activated Natural Killer Cells After Bone Marrow Transplantation for Chronic Myelogenous Leukemia

Immune Thrombocytopenia in Lymphoproliferative Diseases

Interleukin 2-Activated Killer Cells in Patients Following Transplants of Soybean Lectin-Separated and E Rosette-Depleted Bone Marrow

Platelet-bound Complement (C3) in Immune Thrombocytopenia

Platelet-bound complement (C3) in immune thrombocytopenia

Immune thrombocytopenia in lymphoproliferative diseases

Treatment of Chronic Granulocytic Leukemia With Melphalan

Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia

Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow

Treatment of chronic granulocytic leukemia with melphalan

Aktive Filter

Suchergebnisse filtern